25 completed, 5 recruiting, 5 terminated, 5 unknown. 45 Phase 2, 7 Phase 3, 3 Phase 1.
Follow placebo injection: new trials by email Literature Review of placebo injection trials Research Report on placebo injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Efficacy, Safety and Pharmacokinetics of LP-003 in Peanut Allergic Patients LP-003 Injection, Placebo Injection - Peanut Allergies | Phase 2 | Not yet recruiting | Longbio Pharma (Suzhou) Co., Ltd. | 80 | 2026-12-01 | 2026-11-12 |
| Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department Ketamine Injectable Solution, Placebo Injection, Crisis Response Plan - Suicidal Ideation | Phase 2 | Recruiting | The University of Texas Health Science Center at San Antonio | 200 | 2026-09-30 | 2026-10-15 |
| Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection Platelet-Rich Plasma (PRP) Injections, Saline (0.9% NaCl) - Thumb Osteoarthritis | Phase 2 | Recruiting | Goed Medisch Centrum | 88 | 2026-05-20 | 2026-10-05 |
| Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis LP-005 Injection, Placebo Injection - Periodontitis | Phase 2 | Not yet recruiting | Longbio Pharma (Suzhou) Co., Ltd. | 100 | 2026-05-01 | 2026-05-22 |
| Modulation of Cerebral Ischemia by Albumin Albumin infusion, Placebo Injection - Ischemic Stroke | Phase 2 | Recruiting | University Hospital Hradec Kralove | 100 | 2026-02-03 | 2026-05-06 |
| Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction Umbilical Cord-Derived Mesenchymal Stem Cells, Umblical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes, Placebo Intracavernosal Injection - Erectile Dysfunction With Diabetes Mellitus | Phase 2 / Phase 3 | Recruiting | Ankara City Hospital Bilkent | 90 | 2025-12-29 | 2026-03-18 |
| Supplemental Postoperative Bupivacaine Following Non-Surgical Endodontic Treatment Supplemental Postoperative Bupivacaine, Placebo Injection - Pain Assessment, Quality of Life (QOL) | Phase 2 | Recruiting | New York University | 150 | 2024-11-01 | 2026-11-10 |
| A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea HRS9531 Injection, Placebo Injection - Weight Management | Phase 2 | Unknown | Fujian Shengdi Pharmaceutical Co., Ltd. | 108 | 2024-08-01 | 2024-08-22 |
| A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia CM313 Injection, Placebo Injection - Immune Thrombocytopenia, Treatment | Phase 2 | Active not recruiting | Institute of Hematology & Blood Diseases Hospital, China | 45 | 2024-01-16 | 2024-12-30 |
| A Study of HS-20094 Evaluating Weight Loss in Obese and Overweight Chinese Subjects HS-20094, Placebo - Overweight and Obesity | Phase 2 | Completed | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 200 | 2023-10-16 | 2026-06-04 |
| NVG-291 in Spinal Cord Injury Subjects NVG-291, Placebo Injection - Spinal Cord Injuries, Chronic Spinal Cord Injury | Phase 1 / Phase 2 | Completed | NervGen Pharma | 24 | 2023-08-08 | 2026-11-20 |
| Monthly Injectable BUP for MA Use Disorder (MURB) Trial Buprenorphine injection (BUP-Inj), Placebo injection - Methamphetamine-dependence | Phase 2 | Terminated | Madhukar H. Trivedi, MD | 18 | 2023-03-24 | 2025-03-21 |
| Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion Therapy Dengzhanxixin Injection, Placebo injection - Acute Ischemic Stroke | Phase 2 | Unknown | Beijing Tiantan Hospital | 240 | 2022-09-30 | 2023-01-26 |
| Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke Compound Edaravone Injection-Low dose, Compound Edaravone Injection-High dose, Edaravone Injection - Acute Ischemic Stroke | Phase 2 | Suspended | Nanjing Yoko Biomedical Co., Ltd. | 240 | 2021-11-15 | 2024-02-20 |
| Clinical Study of the Safety and Immunogenicity of a Recombinant Viral Vector AAV5 (Adeno-Associated Virus Type 5 )-RBD (Receptor Binding Domain)-S Vaccine for the Prevention of Coronavirus Infection (COVID-19) Low dose BCD-250 injection, High dose BCD-250 injection, Low dose or high dose BCD-250 injection - Coronavirus Infection, COVID-19 | Phase 1 / Phase 2 | Terminated | Biocad | 50 | 2021-08-10 | 2023-01-30 |
| A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients(SUPER-1) Supaglutide injection, placebo injection - Type2 Diabetes | Phase 2 / Phase 3 | Completed | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 547 | 2021-08-03 | 2024-08-07 |
| A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine Sepranolone injection low dose, Sepranolone injection high dose, Placebo injection - Menstrual Migraine | Phase 2 | Completed | Asarina Pharma | 86 | 2019-08-27 | 2021-07-26 |
| Effects of Semaglutide in HIV-Associated Lipohypertrophy Semaglutide Injectable Product, Placebo - HIV/AIDS, Lipohypertrophy | Phase 2 | Completed | Case Western Reserve University | 108 | 2019-05-16 | 2026-10-27 |
| Study to Evaluate the Effect of Lixisenatide in Patient With Parkinson's Disease Lixisenatide, placebo - Parkinson Disease | Phase 2 | Completed | University Hospital, Toulouse | 156 | 2018-06-13 | 2025-11-28 |
Showing 20 of 45. Sign in to see all of them.
Ischemic Stroke (3) · Sciatica (3) · Spinal Cord Injuries (3) · Acquired Immunodeficiency Syndrome (2) · Bone Resorption (2) · Brain Injuries, Traumatic (2) · Central Nervous System Diseases (2) · Diabetes Mellitus, Type 2 (2) · Endocrine System Diseases (2) · Genital Diseases, Male (2) · Gonadal Disorders (2) · Hypogonadism (2) · Motor Activity (2) · Myocardial Ischemia (2) · Nervous System Diseases (2)
Longbio Pharma (Suzhou) Co., Ltd. (2) · PhaseBio Pharmaceuticals Inc. (2) · VA Office of Research and Development (2) · Adynxx, Inc. (1) · Ankara City Hospital Bilkent (1) · Asarina Pharma (1) · Assistance Publique - Hôpitaux de Paris (1) · Baylor College of Medicine (1) · Beijing Tiantan Hospital (1) · Biocad (1) · Bonti, Inc. (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Case Western Reserve University (1) · Christine M. Kleinert Institute for Hand and Microsurgery (1) · Eli Lilly and Company (1)
United States (26) · China (7) · France (3) · Australia (1) · Canada (1) · Czechia (1) · Finland (1) · Iran (1) · Netherlands (1) · Russia (1) · Sweden (1) · Switzerland (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Joshua F Yarrow, PhD MS BS (2) · Allison R Eckard, MD (1) · Anne R. Cappola, MD, ScM (1) · Colleen Fitzgerald, MD (1) · Dalong Zhu, M.D,Ph.D (1) · Dana M Otzel, PhD (1) · Dennis M. Black, PhD (1) · Donald C Manning, MD, PhD (1) · Earvin Liang (1) · Erkan Olcucuoglu, MD, Associate Professor (1)
PMID 19805702, PMID 20506391, PMID 21737787, PMID 22773240, PMID 22791766, PMID 23137499, PMID 23589163, PMID 24793366, PMID 25387217, PMID 26166166, PMID 27151378, PMID 27518486, PMID 28546090, PMID 30224390, PMID 30445896, PMID 30489516, PMID 34438333, PMID 37184744, PMID 38319239, PMID 38598572, PMID 38964353, PMID 39356039, PMID 39722695, PMID 39961992, PMID 40160348, PMID 40744729, PMID 41098140, PMID 41107649, PMID 41120215, PMID 41272211, PMID 42752515, PMID 42921178
2023 (1), I01RX001449 (1), K23AG019161 (1), P30DK019525 (1), R01DA025223 (1), R01DK121619 (1), UL1RR024150 (1)